On April 12, 2011, Mary Beth Hislop from the Los Altos Crier wrote an article about Anne DeGheest's efforts with her new angel group HealthTech Capital: Health care was a $2.5 trillion industry in 2009 - in 2007, $2.2 trillion. It's a safe bet that amount was higher last year, and will be again in 2011. So when seasoned angel investor and Los Altos Hills resident Anne DeGheest realized that 80 percent of that money is spent on health-care delivery systems, she saw an opportunity for investors to support innovations designed to reduce the costs of delivering health care. With a master's degree in engineering from the University of Belgium, a master's degree in business administration from Harvard University and 25 years' investing experience with MedStars Ventures Partners, De Gheest launched Los Altos Hills-based HealthTech Capital in June 2010. Unlike other health-care investor groups that focus on funding startup companies for therapeutic drugs or medical devices, HealthTech's goal is to support technological innovations that improve health-care delivery and reduce costs. "Our sweet spot has minimal or no government regulation oversight by the Food and Drug Administration or centers for Medicare and Medicaid services," DeGheest said. What makes HealthTech's business model special is that startup support involves more than monetary funding. "(This) is a new private-equity investment model that leverages professional investment management oversight with the collegiality and shared expertise found in organized angel-investor groups," she said.